Quantification of Phosphorylated Alpha-synuclein in Cutaneous Biopsies as a Prospective Biomarker in Parkinson's Disease

Clinical trial NCT06621602 · ACTIVE_NOT_RECRUITING

Trial details

NCT number: NCT06621602
Sponsor: CND Life Sciences
Status: ACTIVE_NOT_RECRUITING
Study type: OBSERVATIONAL

REM Behavior Disorder Parkinson Disease

Start date: 2024-12-17
Primary completion: 2026-04-01
Enrollment: 100

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.